RESTART LIFE SCIEN
HEAL.X
Information Services Corp
ISC
Lombard Street Capital Corp
LSC.P
ONCO-INNOVATIONS
ONCO
ZERO CANDIDA TECHNOLOGIES INC
ZCT
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.56%1.8B | 14.03%1.62B | -17.06%2.02B | -0.33%7.56B | -16.37%1.97B | -5.18%1.74B | 2.75%1.42B | 20.74%2.43B | 31.62%7.59B | 26.23%2.36B |
Operating revenue | 3.56%1.8B | 14.03%1.62B | -17.06%2.02B | -0.33%7.56B | -16.37%1.97B | -5.18%1.74B | 2.75%1.42B | 20.74%2.43B | 31.62%7.59B | 26.23%2.36B |
Cost of revenue | -11.34%962M | 11.35%1.03B | 0.93%1.19B | -6.13%4.29B | 1.1B | 1.09B | -13.39%925M | 5.45%1.18B | 26.76%4.57B | |
Gross profit | 28.24%840M | 19.07%587M | -34.03%826M | 8.44%3.28B | 876M | 655M | 58.01%493M | 39.89%1.25B | 39.73%3.02B | |
Operating expense | 5.22%403M | 7.84%399M | 8.66%389M | 12.36%1.48B | 112.36%371M | -74.40%383M | 15.26%370M | 13.29%358M | 7.06%1.32B | -1,065.27%-3B |
Depreciation amortization depletion | 10.15%293M | 10.27%290M | 10.55%283M | 10.19%1.05B | --264M | --266M | 14.35%263M | 11.30%256M | 5.54%952M | ---- |
-Depreciation and amortization | 10.15%293M | 10.27%290M | 10.55%283M | 10.19%1.05B | --264M | --266M | 14.35%263M | 11.30%256M | 5.54%952M | ---- |
Other taxes | -5.98%110M | 1.87%109M | 3.92%106M | 17.98%433M | --107M | --117M | 17.58%107M | 18.60%102M | 11.21%367M | ---- |
Operating profit | 60.66%437M | 52.85%188M | -51.12%437M | 5.41%1.79B | -36.32%505M | -19.76%272M | 1,466.67%123M | 54.40%894M | 83.01%1.7B | 53.68%793M |
Net non-operating interest income (expenses) | -5.80%-237M | -10.90%-234M | -8.85%-246M | -28.95%-882M | -29.28%-234M | -21.74%-224M | -29.45%-211M | -44.87%-226M | -11.95%-684M | -19.87%-181M |
Non-operating interest income | -43.75%9M | -47.06%9M | 200.00%3M | 124.00%56M | --9M | --16M | --17M | --1M | --25M | ---- |
Non-operating interest expense | 2.50%246M | 6.58%243M | 9.69%249M | 32.30%938M | 17.96%243M | 30.43%240M | 39.88%228M | 45.51%227M | 16.04%709M | 36.42%206M |
Other net income (expenses) | -616.67%-186M | 164.20%214M | -11.43%62M | 48.30%261M | 87M | 36M | 50.00%81M | 40.00%70M | -25.42%176M | |
Gain on sale of security | 133.33%6M | -205.56%-19M | ---- | 176.92%20M | --17M | ---18M | --18M | ---- | ---26M | ---- |
Special income (charges) | -2,400.00%-230M | 2,055.56%194M | ---- | -9.52%38M | --11M | --10M | --9M | ---- | -31.15%42M | ---- |
-Less:Other special charges | -50.00%-15M | -33.33%-12M | ---- | 66.96%-38M | ---11M | ---10M | ---9M | ---- | -88.52%-115M | ---- |
-Less:Write off | --221M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --73M | ---- |
-Gain on sale of business | ---24M | --182M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 8.33%13M | -38.89%11M | -20.00%28M | 83.87%57M | --16M | --12M | -14.29%18M | 52.17%35M | -3.13%31M | ---- |
Income before tax | -83.33%14M | 2,500.00%168M | -65.72%253M | -1.76%1.17B | -54.57%358M | -45.81%84M | 94.07%-7M | 56.03%738M | 115.14%1.19B | 86.29%788M |
Income tax | 73.53%-9M | 141.18%21M | -82.72%28M | -30.81%128M | 51M | -34M | 22.73%-51M | 70.53%162M | 3,183.33%185M | |
Earnings from equity interest net of tax | ||||||||||
Net income | -80.51%23M | 234.09%147M | -60.94%225M | 3.57%1.05B | -49.09%307M | -23.87%118M | 184.62%44M | 52.38%576M | 79.86%1.01B | 78.40%603M |
Net income continuous operations | -80.51%23M | 234.09%147M | -60.94%225M | 3.57%1.05B | -49.09%307M | -23.87%118M | 184.62%44M | 52.38%576M | 79.86%1.01B | 78.40%603M |
Noncontrolling interests | 0.00%1M | 0.00%1M | 0 | 1M | 0.00%1M | |||||
Net income attributable to the company | -81.20%22M | 234.09%147M | -60.94%225M | 3.57%1.04B | -43.77%307M | -29.94%117M | 184.62%44M | 52.38%576M | 80.00%1.01B | 62.50%546M |
Preferred stock dividends | 12.50%18M | 12.50%18M | 12.50%18M | 4.76%66M | 18M | 16M | 6.67%16M | 0.00%16M | 26.00%63M | |
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -96.32%3.7M | 360.71%129M | -63.03%207.2M | 3.49%978M | -40.06%289.5M | -39.76%100.6M | 141.79%28M | 54.94%560.4M | 85.29%945M | 49.26%483M |
Diluted earnings per share | -97.30%0.01 | 350.00%0.45 | -64.73%0.73 | 0.28%3.57 | -42.54%1.04 | -41.27%0.37 | 140.00%0.1 | 50.00%2.07 | 79.80%3.56 | 44.80%1.81 |
Basic earnings per share | -97.30%0.01 | 350.00%0.45 | -64.73%0.73 | 0.56%3.57 | -42.54%1.04 | -41.27%0.37 | 140.00%0.1 | 50.00%2.07 | 79.29%3.55 | 44.80%1.81 |
Dividend per share | 3.99%0.7175 | 3.99%0.7175 | 3.99%0.7175 | 4.11%2.7875 | 3.99%0.7175 | 4.15%0.69 | 4.15%0.69 | 4.15%0.69 | 3.98%2.6775 | 4.15%0.69 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.